Trypanosomatid enzymes as targets for plant-derived compounds: New perspectives for phytotherapeutic approaches

Current Enzyme Inhibition

Volumn 7, Issue 1, 2011, Pages 32-41

  de Almeida Rodrigues, Igor ^a   Amaral, Ana Claudia Fernandes ^b   do Socorro dos Santos Rosa, Maria ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Enzymes; Leishmania; Phytochemicals; Trypanosoma

Indexed keywords

2' HYDROXY 3,4,4' TRIMETHOXY 5',6' (2'',2'' DIMETHYLPYRANO)CHALCONE; 2' HYDROXY 4,4' DIMETHOXY 5',6' (2'',2'' DIMETHYLPYRANO)CHALCONE; 3',4' METHYLENEDIOXY 5,7 DIMETHOXYFLAVONE; ALKALOID; BETULIC ACID; CAMPTOTHECIN; COUMARIN; CYSTEINE PROTEINASE INHIBITOR; DIHYDRO BETULINIC ACID; DIOSPYRIN; ENZYME; ETOPOSIDE; FLAVONOID; KOMAROVIQUINONE; LICOCHALCONE A; LINALOOL; LUTEOLIN; NEROLIDOL; OXALIC BIS[(2 HYDROXY 1 NAPHTHYL)METHYLENE]HYDRAZIDE; PLANT MEDICINAL PRODUCT; POLYCARPOL; PROTEINASE INHIBITOR; QUERCETIN; QUINONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASICINE; VINYLSULFONYLBENZENE DERIVATIVE; WITHAFERIN A;

ANTILEISHMANIAL ACTIVITY; BACOPA MONNIERI; CAMPTOTHECA ACUMINATA; CHAGAS DISEASE; CHIRATA; DRACOCEPHALUM KOMAROVI; DRUG ACTIVITY; DRUG APPROVAL; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; FOOD AND DRUG ADMINISTRATION; GERANIUM BELLUM; HUMAN; KINETOPLASTID LIFE CYCLE STAGE; LEISHMANIA; LEISHMANIASIS; MEDICINAL PLANT; MUSA ACUMINATA; NEORAPUTIA MAGNIFICA; NONHUMAN; PARASITE VIRULENCE; PEGANUM HARMALA; PERSIMMON; PHYTOTHERAPY; PIPTOSTIGMA PREUSSI; REVIEW; TRADITIONAL MEDICINE; TRYPANOSOMA; TRYPANOSOMIASIS; VITEX NEGUNDO; WITHANIA SOMNIFERA;

TRYPANOSOMA; TRYPANOSOMATIDAE;

EID: 79958201204     PISSN: 15734080     EISSN: 18756662     Source Type: Journal    
DOI: 10.2174/157340811795713792     Document Type: Review

References (57)

1. Kennedy, P.G.E. Human African trypanosomiasis of the CNS: current issues and challenges. J. Clin. Investig., 2004, 113, 496-504.
2. World Health Organization. Chagas'disease. Weekly epidemiology records, 1998, 1/2, 1.
3. Croft, S.L.; Sundar, S.; Fairlamb, A.H. Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev., 2006, 19, 111-126.
4. Ashford, R.W.; Desjour, P.; DeRaadt, P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol. Today, 1992, 8, 104-105.
5. Dhiman, R.C.; Pahwa S.; Dhillon, G.P.; Dash, A.P. Climate change and threat of vector-borne diseases in India: are we prepared? Parasitol. Res., 2010, 106, 763-773.
6. Urbina, J.A. Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches. Acta Tropica, 2010, 115, 55-68.
7. Croft, S.L.; Seifert, K.; Yardley, V. Current scenario of drug development for leishmaniasis. Indian J. Med. Res., 2006, 123, 399-410.
8. McKerrow, J.H.; Caffrey, C; Kelly, B.; Loke, P.; Sajid, M. Proteases in Parasitic Diseases. Annu. Rev. Pathol. Mech. Dis., 2006, 1, 497-536.
9. Dedet, J.P.; Pratlong, F.; Lanotte, G.; Ravel, C. Cutaneous leishmaniasis. The parasite. Clin. Dermatol. 1999, 17, 261-268.
10. Prata, A. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect. Dis., 2001, 1, 92-100.
11. Da Mata, J.R.; Camargos, M.R.; Chiari, E.; Machado, C.R. Trypanosoma cruzi infection and the rat central nervous system: proliferation of parasites in astrocytes and the brain reaction to parasitism. Brain Res. Bull., 2000, 53, 153-162.
12. Paluzzi, J.P.; Russell, W.K.; Nachman, R.J.; Orchard I. Isolation, cloning and expression mapping of a gene encoding an anti-diuretic hormone and other CAPA-related peptides in the disease vector, Rhodnius prolixus. Endocrinology, 2008, 149, 4638-46.
13. Mendonça-Filho, R.R.; Rodrigues, I.A.; Alviano, D.S.; Santos, A.L.S.; Soares, R.M.A.; Alviano, C.S.; Lopes, A.H.C.S.; Rosa, M.S.S. Leishmanicidal activity of polyphenolic-rich extract from husk fiber of Cocos nucifera Linn. (Palmae). Res. Microbiol, 2004, 155, 136-143.
14. Descoteaux, A.; Turco, SJ. Glycoconjugates in Leishmania infec-tivity. Biochim. Biophys. Acta, 1999, 1455, 341-352.
15. Gantt, K.R.; Goldman, T.L.; McCormick, M.L.; Miller, M.A.; Jeronimo, S.M.B.; Nascimento, E.T.; Britigan, B.E.; Wilson, M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol, 2001, 167, 893-901.
16. Firenzuoli, F.; Gori, L. Herbal medicine today: clinical and research issues. eCAM, 2007, 4(S1), 37-40.
17. Basso, L.A.; Silva, L.H.P.; Fett-Neto, A.G.; Junior, W.F.A.; Mor-eira, I.S.; Palma, M.S.; Calixto, J.B.; Astolfi-Filho, S.; Santos, R.R; Soares, M.B.P.; Santos, D.S. The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases - A Review. Mem. Inst. Oswaldo Cruz, 2005, 100, 575-606.
18. Rates, S.M.K. Plants as source of drugs. Toxicon, 2001, 39, 603-613.
19. Chan-Bacab, M.J.; Penã-Rodriguez, L.M. Plant natural products with leishmanicidal activity. Nat. Prod. Rep., 2001, 18, 674-688.
20. Arribas, J.R.; Pulido, F.; Delgado, R.; Lorenzo, A.; Miralles, P.; Arranz, A.; González-García, J.J.; Cepeda, C; Hervás, R.; Paño, J.R.; Gaya, F.; Carcas, A.; Montes, M.L.; Costa, J.R.; Peña, J.M. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J. Ac-quir. Immune Defic. Syndr., 2005, 40, 280-287.
21. Selzer, P.M.; Pingel, S.; Hsieh, I.; Ugele, B.; Chan, V.J.; Engel, J.C.; Bogyo, M.; Russell, D.G.; Sakanari, J.A. McKerrow J.H. Cysteine protease inhibitors as chemotherapy: lessons from a parasite target. Proc. Natl. Acad. Sci. USA, 1999, 96, 11015-11022.
22. Sher, A. Antimicrobial activity of natural products from medicinal plants. Gomal J. Med. Sci., 2009, 7, 72-78.
23. Trapp, S.C.; Croteau, R.B. Genomic organization of plant terpene synthases and molecular evolutionary implications. Genetics, 2001, 158, 811-832.
24. Arruda, D.C.; D'Alexandri, F.L.; Katzin, A.M.; Uliana, S.R.B. Antileishmanial activity of the terpene nerolidol. Antimicrob. Agents Chemother., 2005, 49, 1679-1687.
25. Urbina, J.A.; Concepcion, J.L.; Caldera, A.; Payares, G.; Sanoja, C; Otomo, T.; Hiyoshi, H. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob. Agents Chemother., 2004, 48, 2379-2387.
26. Rosa, M.S.S.; Mendonça-Filho, R.R.; Bizzo, H.R.; Rodrigues, I.A.; Soares, R.M.A.; Souto-Padron, T.; Alviano, C.S.; Lopes, A.H.C.S. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob. Agents Chemother., 2003, 47, 1895-1901.
27. Wang, J.C. DNA topoisomerases. Annu. Rev. Biochem., 1996, 65, 635-692.
28. Yogeeswari, P.; Sriram, D. Betulinic acid and its derivatives: a review on their biological properties. Curr. Med. Chem., 2005, 12, 657-666.
29. Syrovets, T.; Buchele, B.; Gedig, E.; Slupsky, J.R.; Simmet, T. Acetyl boswellic acids are novel catalytic inhibitors of human topoisomerase I and II. Mol. Pharmacol., 2000, 58, 71-81.
30. Chowdhury, A.R.; Mandal, S.; Goswami, A.; Ghosh, M.; Mandal, L.; Chakraborty, D.; Ganguly, A.; Tripathi, G.; Mukhopadhyay, S.; Bandyopadhyay, S.; Majumder, H.K. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoi-somerase I and II: implications in antileishmanial therapy. Mol. Med., 2003, 9, 26-36.
31. Domínguez-Carmona, D.B.; Escalante-Erosa, F.; García-Sosa, K.; Ruiz-Pinell, G.; Gutierrez-Yapu, D.; Chan-Bacab, M.J.; Giménez-Turba, A.; Peña-Rodríguez, L.M. Antiprotozoal activity of betu-linic acid derivatives. Phytomedicine, 2010, 17, 379-82.
32. Tomazela, D.M.; Pupo, M.T.; Passador, E.A.P. Silva, M.F.G.F.; Vieira, P.C.; Fernandes, J.B.; Fo, E.R.; Oliva, G.; Pirani, J.R. Pyrano chalcones and a flavone from Neoraputia magnifica and their Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase-inhibitory activities. Phytochemistry, 2000, 55, 643-651.
33. Chen, M.; Christensen, S.B.; Blom, J.; Lemmich, E.; Nadelmann, L.; Fich, K.; Theander, T.G.; Kharazmi, A. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob. Agents Che-mother., 1993, 37, 2550-2556.
34. Chen, M.; Christensen, S.B.; Theander, T.G.; Kharazmi, A. An-tileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania dono-vani. Antimicrob. Agents Chemother., 1994, 38, 1339-1344.
35. Zhai, L.; Blom, J.; Chen, M.; Christensen, S.B.; Kharazmi, A. The antileishmanial agent Licochalcone A interferes with the function of parasite mitochondria. Antimicrob. Agents Chemother., 1995, 39, 2742-2748.
36. Chen, M.; Zhai, L.; Christensen, S.B.; Theander, T.G.; Kharazmi, A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob. Agents Chemother., 2001, 45, 2023-2029.
37. Mittra, B.; Saha, A.; Chowdhury, A.R.; Pal, C.; Mandal, S.; Muk-hopadhyay, S.; Bandyopadhyay, S.; Majumder, H.K. Luteolin, an abundant dietary component is a potent anti leishmanial agent that acts by inducing topoisomerase II-mediated kinteoplast DNA cleavage leading to apoptosis. Mol. Med., 2000, 6, 527-541.
38. Sen, N.; Banerjee, B.; Das, B.B.; Ganguly, A.; Sen, T.; Pramanik, S.; Mukhopadhyay, S.; Majumder, H.K. Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex. Cell Death Differ., 2007, 14, 358-367.
39. Ngantchou, I.; Nkwengoua, E.; Nganso, Y.; Nyasse, B.; Denier, C.; Hannaert, V.; Schneider, B. Antitrypanosomal activity of polycar-pol from Piptostigma preussi (Annonaceae). Fitoterapia, 2009, 80, 188-191.
40. Uchiyama, N.; Kabututu, Z.; Kubata, B.K.; Kiuchi, F.; Ito, M.; Nakajima-Shimada, J.; Aoki, T.; Ohkubo, K.; Fukuzumi, S.; Martin, S.K.; Honda, G.; Urade, Y. Antichagasic activity of koma-roviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme. Antimicrob. Agents Chemother., 2005, 49, 5123-5126.
41. Ray, S.; Hazra, B.; Mittra, B.; Das, A.; Majumder, H.K. Diospyrin, a bisnapthaquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani. Mol. Pharmacol., 1998, 54, 994-999.
42. Barbosa-Filho, J.M.; Piuvezam, M.R.; Moura, M.D.; Silva, M.S.; Lima, K.V.B.; da-Cunha, E.V.L.; Fechine, I.M., Takemura, O.S. Anti-inflammatory activity of alkaloids: a twenty-century review. Rev. Bras. Farmacogn., 2006, 16, 109-139.
43. Bodley, A.L.; Shapiro, T.A. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor on trypanosomes and Leishmania. Proc. Natl. Acad. Sci. USA, 1995, 92, 3726-3730.
44. Sen, N.; Das, B.B.; Ganguly, A.; Mukherjee, T.; Tripathi, G.; Ban-dyopadhyay, S.; Rakshit, S.; Sen, T.; Majumder, H.K. Camptothe-cin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ., 2004, 11, 924-936.
45. Misra, P.; Khaliq, T.; Dixit, A.; SenGupta, S.; Samant, M.; Kumari, S.; Kumar, A.; Kushawaha, P.K.; Majumder, H.K.; Saxena, A.K.; Narender, T.; Dube, A. Antileishmanial activity mediated by apop-tosis and structure-based target study of peganine hydrochloride di-hydrate: an approach for rational drug design. J. Antimicrob. Che-mother., 2008, 62, 998-1002.
46. Nafisi, S.; Bonsaii, M.; Maali, P.; Khalilzadeh, M.A.; Manouche-hri, F. beta-Carboline alkaloids bind DNA. J. Photochem. Photo-biol. B., 2010, 100, 84-91.
47. Di Giorgio, C.; Delmas, F.; Ollivier, E.; Elias, R.; Balansard, G.; Timon-David, P. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp. Parasitol., 2004, 106, 67-74.
48. Vannier-Santos, M.A.; Martiny, A.; Meyer-Fernandes, J.R.; de Souza, W. Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Eur. J. Cell Biol., 1995, 67, 112-119.
49. Cappiello, A.; Famiglini, G.; Mangani, F.; Tirillini, B. Analysis of coumarins by micro high-performance liquid chromatography-mass spectrometry with a particle beam interface. J. Am. Soc. Mass Spec-trom., 1995, 6, 132-139.
50. de Marchi, A.A.; Castilho, M.S.; Barboni, P.G.N.; Archanjo, F.C.; Del Ponte, G.; Olivab, G.; Pupo, M.T. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydro-genase (gGAPDH) from Trypanosoma cruzi. Bioorg. Med. Chem., 2004, 12, 4823-4833.
51. Menezes, I.R.; Lopes, J.C.; Montanari, C.A.; Oliva, G.; Pavão, F.; Castilho, M.S.; Vieira, P.C.; Pupo, M.T. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi. J. Comput. Aided Mol. Des., 2003, 17, 277- 290.
52. Opitz, S.; Schnitzler, J.P.; Hause, B.; Schneider, B. Histochemical analysis of phenylphenalenone-related compounds in Xiphidium caeruleum (Haemodoraceae). Planta, 2003, 216, 881-889.
53. Luque-Ortega, J.R.; Martínez, S.; Saugar, J.M.; Izquierdo, L.R.; Abad, T.; Luis, J.G.; Pinero, J.; Valladares, B.; Rivas, L. Fungus-licited metabolites from plants as an enriched source for new leishmanicidal agents: antifungal phenyl-phenalenone phytoalexins from the banana plant (Musa acuminata) target mitochondria of Leishmania donovani promastigotes. Antimicrob. Agents Che-mother., 2004, 48, 1534-1540.
54. Sampaio-Santosa, M.I.; Kaplan, M.A.C. Biosynthesis Significance of Iridoids in Chemosystematics. J. Braz. Chem. Soc., 2001, 12, 144-153.
55. Ray, S.; Majumder, H.K.; Chakravarty, A.K.; Mukhopadhyay, S.; Gil, R.R.; Cordell, G.A. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoi-somerase I from Leishmania donovani. J. Nat. Prod., 1996, 59, 27-29.
56. Simões, C.M.O.; Schenkel, E.P.; Gosmann, G.; Mello, J.C.P.; Mentz, L.A.; Petrovick, P.R. Farmacognosia: da planta ao medica-mento. Editora da Universidade UFRGS: Porto Ale-gre/Florianópolis, 3rd ed., 2001.
57. Gayosso-De-Lucio, J.; Torres-Valencia, M.; Rojo-Domínguez, A.; Nájera-Peña, H.; Aguirre-López, B.; Salas-Pacheco, J.; Avitia-Domínguez, C.; Téllez-Valencia, A. Selective inactivation of tri-osephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose. Bio-org. Med. Chem. Lett., 2009, 19, 5936-5939.